Study guide
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision
AACVPR CCRP Certified Cardiac Rehab Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Cardiac Rehabilitation Foundations
1.1 AACVPR CCRP Credential, Exam Specifications & Core Competencies 1.2 Phases of Cardiac Rehabilitation & Clinical Delivery Models 1.3 Interdisciplinary Team Roles, Clinical Scope of Practice & Safety
2 Chapter 2: Cardiovascular Anatomy, Physiology & Pathology
2.1 Cardiac Anatomy, Coronary Circulation & Hemodynamics 2.2 Atherosclerosis Pathogenesis, Acute Coronary Syndromes (ACS) & Revascularization 2.3 Heart Failure (HFrEF/HFpEF), Cardiomyopathies & Valvular Heart Disease 2.4 Electrical Interventions: Cardioversion, Catheter Ablation & Post-Procedure Rehabilitation
3 Chapter 3: Diagnostic Evaluation, ECG & Clinical Testing
3.1 Baseline Clinical Assessment & AACVPR Risk Stratification 3.2 12-Lead ECG Interpretation: Ischemia, Transmural Infarction & Conduction 3.3 Cardiac Arrhythmias, Conduction Blocks & Device Rhythms (Pacemakers/ICDs) 3.4 Graded Exercise Testing (GXT), Gas Exchange & Termination Criteria
4 Chapter 4: Patient-Centered Assessment: Education, Equity & Social Context
4.1 Learning Readiness: Health Literacy, Learning Styles & Communication Barriers 4.2 Social Determinants of Health, Culture & Spirituality in Cardiac Rehab 4.3 Sex- and Race-Based Differences in Cardiovascular Presentation & Outcomes 4.4 Substance Use Screening: Alcohol, Cannabis, Stimulants & Cardiac Risk
5 Chapter 5: Exercise Prescription & Aerobic Conditioning
5.1 FITT-VP Framework & Aerobic Exercise Intensity Calculation 5.2 Exercise Progression, Environmental Factors & Telemetry Monitoring Guidelines 5.3 High-Intensity Interval Training (HIIT) vs Moderate Continuous Training (MICT) 5.4 Home Exercise Program Design, Prescription & Independent Progression
6 Chapter 6: Exercise Physiology, Monitoring & Session Design
6.1 Health-Related Physical Fitness Components & Functional Capacity Testing 6.2 Acute Cardiovascular Responses to Aerobic Exercise: METs, Rate Pressure Product & VO₂ 6.3 Chronic Training Adaptations in Cardiac Patients 6.4 Structuring the Exercise Session: Warm-Up, Conditioning & Cool-Down 6.5 ECG Telemetry Setup: Skin Preparation, Electrode Placement & Artifact Troubleshooting 6.6 Pulse Oximetry, Exertional Desaturation & Supplemental Oxygen Titration
7 Chapter 7: Resistance, Flexibility & Exercise Safety
7.1 Resistance Training Guidelines, Hemodynamics & Sternal Precautions 7.2 Flexibility, Neuromotor Training & Special CR Populations 7.3 Exercise Contraindications, Adverse Signs/Symptoms & Emergency Protocols
8 Chapter 8: Physical Activity Counseling & Behavior Change
8.1 Physical Activity Guidelines, Sedentary Physiology & NEAT 8.2 Behavioral Change Theories: Transtheoretical Model & Social Cognitive Theory 8.3 Motivational Interviewing Principles & Resolving Ambivalence 8.4 SMART Goal Setting, Activity Tracking & Relapse Prevention
9 Chapter 9: Physical Activity Assessment & Real-World Activity Counseling
9.1 Physical Activity vs Exercise: Assessment Instruments, Logs & Wearables 9.2 Metabolic Requirements of Daily Life: Occupational, Recreational & Sexual Activity 9.3 Environmental & Situational Risk: Heat, Cold, Altitude, Air Quality & High-Risk Activities 9.4 Upper- vs Lower-Body Physiologic Demands & Modality Selection
10 Chapter 10: Hypertension & Blood Pressure Regulation
10.1 2017 ACC/AHA Hypertension Classification & Cardiovascular Risk 10.2 Antihypertensive Pharmacology & Exercise Hemodynamics 10.3 Exertional Blood Pressure Dynamics, Exertional Hypotension & Crisis 10.4 Home Blood Pressure Monitoring, Sodium Restriction & Lifestyle Interventions 10.5 Blood Pressure Measurement Technique, Device Validation & Renal Protection
11 Chapter 11: Diabetes Mellitus & Metabolic Regulation
11.1 Diabetes Pathophysiology, Diagnostic Criteria & Glycemic Targets 11.2 Antidiabetic Pharmacotherapy (Insulin, Sulfonylureas, SGLT2i, GLP-1 RA) 11.3 Exercise-Induced Hypoglycemia Management (Rule of 15) & Hyperglycemia 11.4 Diabetic Complications & Exercise Adaptations (Autonomic & Peripheral Neuropathy) 11.5 Blood Glucose Self-Monitoring, CGM Interpretation & Peri-Exercise Testing 11.6 Diabetic Foot Care, Skin Integrity & Footwear Assessment
12 Chapter 12: Blood Lipid Management & Atherosclerosis Prevention
12.1 Lipid Metabolism, Atherogenic Lipoproteins & Advanced Lipid Testing 12.2 Statin Therapy, Dosing Intensity & Secondary Prevention Targets 12.3 Non-Statin Pharmacotherapies & Statin-Associated Muscle Symptoms (SAMS)
13 Chapter 13: Medical Nutrition Therapy & Dietary Patterns
13.1 Nutritional Assessment & Macronutrient Guidelines in Cardiovascular Disease 13.2 Cardioprotective Dietary Patterns: Mediterranean, DASH & Plant-Based 13.3 Dietary Lipids, Sodium, Soluble Fiber & Plant Stanols/Sterols 13.4 Clinical Scope: CR Professional Counseling Boundaries vs RD/RDN Referral
14 Chapter 14: Body Composition & Weight Management
14.1 Anthropometric Assessment: BMI, Waist Circumference & Obesity Paradox 14.2 Behavioral Weight Management, Energy Balance & Caloric Deficits 14.3 Anti-Obesity Pharmacotherapy (GLP-1/GIP) & Bariatric Surgery Considerations
15 Chapter 15: Tobacco Cessation Interventions
15.1 Cardiovascular Pathophysiology of Tobacco, Nicotine & Secondhand Smoke 15.2 Clinical Cessation Frameworks: The 5 A's & 5 R's Models 15.3 Pharmacotherapy for Nicotine Dependence: NRT, Varenicline & Bupropion 15.4 Behavioral Counseling, Coping Strategies & Relapse Prevention
16 Chapter 16: Psychosocial Health, Screening & Behavioral Support
16.1 Psychosocial Risk Factors & Prognostic Impact in Heart Disease 16.2 Validated Screening Instruments: PHQ-9, GAD-7 & Administration 16.3 Evidence-Based Interventions: Stress Management, CBT Principles & Social Support 16.4 Crisis Protocols, Suicidal Ideation & Mental Health Referral Pathways 16.5 Psychotropic Pharmacology & Cardiac Safety 16.6 Sleep Disturbance, Chronic Pain & Somatic Comorbidity in Psychosocial Management
17 Chapter 17: Regulatory Compliance, Documentation & Program Outcomes
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision 17.2 Individualized Treatment Plan (ITP) Components, 30-Day Updates & Goals 17.3 AACVPR Outcome Domains & Program Certification Performance Measures 17.4 Program Certification, Quality Improvement & Medical Emergency Preparedness
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision
Key Takeaways Explain This Topic AI
Under CMS National Coverage Determination (NCD) 20.10 and 42 CFR § 410.49, exactly seven cardiac indications qualify for Medicare Part B coverage: AMI within preceding 12 months, CABG, current stable angina pectoris, heart valve repair/replacement, PCI, heart or heart-lung transplant, and stable chronic heart failure (HFrEF).
Qualifying chronic heart failure requires a documented left ventricular ejection fraction (LVEF) <=35%, NYHA Class II to IV symptoms despite >=6 weeks of stable guideline-directed medical therapy (GDMT), and no cardiovascular hospitalizations or planned major cardiovascular procedures within the preceding 6 weeks.
Standard Phase II cardiac rehabilitation authorizes up to 36 one-hour sessions with a statutory cap of no more than 2 one-hour sessions per calendar day, delivered over a regulatory window of up to 36 weeks (typical practice is 2-3 sessions weekly across 12 to 18 weeks).
Intensive Cardiac Rehabilitation (ICR) expands coverage up to 72 one-hour sessions (up to 6 sessions per day over 18 weeks) through CMS-approved proprietary lifestyle programs demonstrating angiographic reversal of CAD or reduction in cardiac events.
Effective January 1, 2024, direct supervision may be furnished by a physician (MD or DO) or by a physician assistant, nurse practitioner, or clinical nurse specialist, who must be immediately available and accessible on the premises whenever cardiac rehabilitation services are furnished.
Last updated: September 2026
17.1 CMS Coverage Guidelines, Qualifying Diagnoses & Practitioner Supervision
Note
Regulatory Framework : Outpatient cardiac rehabilitation (CR) reimbursement under Medicare Part B is governed by statutory law under the Medicare Improvements for Patients and Providers Act (MIPPA) of 2008, codified in the Code of Federal Regulations at 42 CFR § 410.49 , and interpreted clinically through the Centers for Medicare & Medicaid Services (CMS) National Coverage Determination (NCD) 20.10 . Adherence to these strict qualifying criteria and supervisory mandates is required to prevent claim denials, recoupments, and False Claims Act liability.
Cardiac rehabilitation is an evidence-based secondary prevention model proven to reduce all-cause mortality by 20% to 30%, decrease hospital readmissions, and enhance functional capacity. However, federal reimbursement is strictly conditioned on compliance with statutory diagnostic indications, session utilization limits, and medical oversight standards. Clinical professionals preparing for the CCRP examination must master the precise diagnostic thresholds, session parameters, and direct supervision rules governing Phase II outpatient programs.
Statutory Authority & Qualifying Indications
Under 42 CFR § 410.49 and CMS NCD 20.10 , Medicare Part B reimburses outpatient cardiac rehabilitation services exclusively for patients who meet one of seven distinct clinical qualifying diagnoses :
Acute Myocardial Infarction (AMI) : Must have occurred within the preceding 12 months prior to the date of starting cardiac rehabilitation. Any documented ST-elevation MI (STEMI) or non-ST-elevation MI (NSTEMI) within 365 calendar days satisfies this criterion.
Coronary Artery Bypass Graft (CABG) Surgery : Surgical myocardial revascularization utilizing arterial (e.g., internal mammary artery) or venous grafts. Unlike AMI, CMS statute does not impose a strict 12-month cutoff for CABG; however, enrollment typically commences 4 to 8 weeks postoperatively following sternal stabilization.
Current Stable Angina Pectoris : Requires documented objective clinical evidence of myocardial ischemia. Acceptable medical documentation includes positive stress electrocardiography, stress echocardiography, nuclear myocardial perfusion imaging, cardiac magnetic resonance, or angiographic demonstration of flow-limiting coronary stenoses with persistent exertional symptoms classified under Canadian Cardiovascular Society (CCS) Class II, III, or IV.
Heart Valve Repair or Replacement : Surgical or transcatheter repair or replacement of one or more cardiac valves (aortic, mitral, tricuspid, or pulmonary). This includes surgical mechanical or bioprosthetic valve replacement, Transcatheter Aortic Valve Replacement (TAVR), and Transcatheter Edge-to-Edge Repair (TEER, such as MitraClip).
Percutaneous Coronary Intervention (PCI) : Transluminal coronary revascularization via balloon angioplasty, rotational or orbital atherectomy, or intracocoronary stent implantation (drug-eluting or bare-metal stents).
Heart Transplant or Heart-Lung Transplant : Orthotopic or heterotopic heart transplantation, or combined heart-lung transplantation, for end-stage cardiopulmonary disease.
Stable Chronic Heart Failure (HFrEF) : Added via CMS national coverage expansion in 2014, heart failure qualifies only when meeting all four specific criteria :
Documented Left Ventricular Ejection Fraction (LVEF) <= 35% (heart failure with reduced ejection fraction) by echocardiography, radionuclide ventriculography, or cardiac MRI.
New York Heart Association (NYHA) Class II, III, or IV functional symptoms.
Maintained on stable optimal guideline-directed medical therapy (GDMT) —including beta-blockers, ACE inhibitors/ARBs/ARNIs, aldosterone antagonists, and SGLT2 inhibitors—for at least 6 weeks prior to initiating rehabilitation.
Clinically stable condition, defined as having had no hospitalizations for cardiovascular reasons and no planned major cardiovascular procedures within the preceding 6 weeks .
Non-Covered Diagnoses and Common Audit Traps
Medicare does not cover cardiac rehabilitation for several prevalent cardiovascular conditions, even when clinically beneficial. Common non-covered conditions include:
Isolated permanent pacemaker or implantable cardioverter-defibrillator (ICD) implantation in the absence of a separate qualifying diagnosis (such as HFrEF with LVEF <=35% or recent AMI).
Heart Failure with Preserved Ejection Fraction (HFpEF; LVEF >35%).
Congenital heart disease, hypertrophic cardiomyopathy, or thoracic aortic aneurysm repair (unless accompanied by a covered valve or CABG procedure).
Unstable angina pectoris (represents an absolute contraindication to exercise).
Peripheral Artery Disease (PAD): Covered under a separate, distinct CMS benefit— Supervised Exercise Therapy (SET) for Symptomatic PAD (NCD 20.33) —which has its own distinct billing codes (CPT 93668) and supervisory rules.
Session Allowances: Standard CR vs. Intensive CR (ICR)
CMS establishes explicit session caps, daily frequency limits, and longitudinal time frames under 42 CFR § 410.49:
- Program Parameter Standard Cardiac Rehabilitation (CR) Intensive Cardiac Rehabilitation (ICR)
- Statutory Authority 42 CFR § 410.49; NCD 20.10 42 CFR § 410.49; MIPPA Section 144
- Initial Session Cap Up to 36 one-hour sessions Up to 72 one-hour sessions
- Daily Session Cap Maximum 2 one-hour sessions per day Maximum 6 one-hour sessions per day
Duration / Delivery Window Regulatory window is up to 36 weeks for the initial 36 sessions (typical delivery is 2-3 sessions/week over 12 to 18 weeks) Up to 18 consecutive weeks
Time Threshold per Session Minimum 31 minutes for a 1-hour unit (CPT 93797/93798) Minimum 31 minutes per ICR unit (HCPCS G0422/G0423)
Curricular Models Facility-developed interdisciplinary exercise & risk reduction CMS-approved proprietary programs: Pritikin, Ornish, Benson-Henry
Statutory Evidence Requirement Established clinical efficacy across 7 qualifying indications Proven to reverse CAD progression or reduce CABG/PCI rates
For standard Phase II CR, the statutory maximum is 36 sessions. A program may request an additional 36 sessions (up to 72 sessions total) only if the Medicare Administrative Contractor (MAC) determines that additional sessions are medically necessary (e.g., extreme deconditioning following prolonged critical illness), though routine approvals are rare.
Direct Physician Supervision Requirements
Under 42 CFR § 410.49 , cardiac rehabilitation services must be furnished under direct supervision . Effective January 1, 2024 , the supervising practitioner may be a physician (MD or DO) or a nonphysician practitioner — a physician assistant, nurse practitioner, or clinical nurse specialist — following the CY 2024 Physician Fee Schedule final rule codifying Section 51008 of the Bipartisan Budget Act of 2018. A physician still serves as the program medical director . Direct supervision requires:
1. The "Immediately Available and Accessible" Mandate
Immediate Availability : The supervising practitioner must be immediately available and accessible for medical consultations and emergency interventions at all times when patients are receiving cardiac rehabilitation services. Direct supervision does not require presence in the exercise room itself.
Virtual Presence Is Permitted : Under 42 CFR § 410.27(a)(1)(iv)(B)(1), presence for the purpose of supervising cardiac, intensive cardiac, and pulmonary rehabilitation includes virtual presence through real-time audio/video communications technology (audio-only does not qualify) . This is codified regulation text, not a temporary public health emergency waiver, so a supervising practitioner joining by real-time two-way video satisfies direct supervision.
No Physical Encumbrances : The supervising practitioner cannot be performing an un-interruptible procedure (e.g., performing cardiac catheterization, major surgery, or endoscopy) that would prevent immediate physical arrival at the CR exercise pavilion in the event of a clinical emergency.
Setting-Specific Rules : 42 CFR § 410.49(b)(3)(ii) defers to the incident-to supervision rules — § 410.26 for physician-office programs and § 410.27 for hospital outpatient departments. In a physician-office program the practitioner is present in the office suite; in a hospital outpatient department the practitioner is immediately available in the department, and in both settings the virtual-presence allowance above applies.
2. Supervising Practitioner Qualifications
Under 42 CFR § 410.49(e), a physician or nonphysician practitioner acting as the supervising practitioner must possess both of the following — and only these two are regulatory minimums:
Expertise in the management of individuals with cardiac pathophysiology.
Cardiopulmonary training in basic life support or advanced cardiac life support.
Important
The regulation reads "basic life support or advanced cardiac life support," not "and." A common exam distractor asserts that both BLS and ACLS certification are federally mandated for the supervising practitioner. Most programs require ACLS as an internal policy and AACVPR Program Certification expects it of staff, but that is institutional policy, not 42 CFR § 410.49.
The medical director carries an additional requirement under § 410.49(d): the same cardiac expertise and BLS-or-ACLS training, plus licensure to practice medicine in the state where the program is offered.
3. Non-Physician Practitioners (NPPs)
Under statutory updates enacted through the Bipartisan Budget Act of 2018 (effective January 1, 2024), physician assistants (PAs), nurse practitioners (NPs), and clinical nurse specialists (CNSs) are legally permitted to furnish direct supervision for cardiac rehabilitation programs, provided they satisfy state scope of practice laws and program credentialing requirements.
Clinical & Administrative Matrix: CMS Qualifying Indications
Qualifying Indication Diagnostic Threshold / Verification Documentation Required in Patient Chart Common Audit Vulnerability
Acute Myocardial Infarction Biomarker elevation (troponin) + ischemic symptoms/ECG; <=12 months Inpatient discharge summary, troponin curves, catheterization report Enrollment >365 days post-infarction without an interim event
CABG Surgery Surgical bypass grafting with saphenous vein or internal mammary Operative note detailing grafts placed, sternotomy recovery Missing operative report or failure to verify sternal stability
Stable Angina Pectoris CCS Class II-IV symptoms + objective stress/angiographic ischemia Stress test tracing/report, catheterization showing >70% stenosis Relying solely on patient symptom history without objective testing
Valve Repair / Replacement Surgical or transcatheter intervention (SAVR, TAVR, TEER) Surgical or catheterization operative note, post-procedure echo Confusing valvular disease without intervention with a repair/replacement
PCI Balloon angioplasty, stent placement, or atherectomy Angiography report detailing vessel, lesion, and stent deployment Coding diagnostic angiography alone without actual therapeutic intervention
Heart / Heart-Lung Transplant Orthotopic organ transplantation Operative report, immunosuppressive regimen, endomyocardial biopsy Enrolling pre-transplant mechanical circulatory support without transplant
Stable Chronic Heart Failure LVEF <=35%, NYHA II-IV, stable GDMT >=6 wks, no CV hosp/proc in 6 wks Recent echocardiogram/MRI, pharmacy refill records, clinic notes Missing documentation of 6-week GDMT or recent heart failure hospitalization
Realistic Administrative Scenario: Heart Failure Audit Defense
Compliance Scenario : During an internal compliance audit of an outpatient cardiac rehabilitation department, the compliance officer flags a Medicare claim for a 68-year-old male enrolled under the chronic heart failure diagnosis. The chart contains an echocardiogram from 2 months prior documenting an LVEF of 30% and an intake note describing NYHA Class III dyspnea. However, further review reveals that 3 weeks prior to CR intake, the patient was admitted to the hospital for 48 hours for intravenous furosemide diuresis following acute decompensated heart failure. Additionally, his sacubitril/valsartan dose was adjusted from 24/26 mg to 49/51 mg upon discharge.
Regulatory Analysis & Corrective Action :
Non-Compliance Finding : Under CMS NCD 20.10, the patient violates two mandatory coverage criteria: he experienced a cardiovascular hospitalization within the preceding 6 weeks, and his guideline-directed medical therapy has not been stable for at least 6 weeks.
Financial Risk : Billing Medicare for sessions delivered under these circumstances constitutes an improper claim subject to full payment recoupment and potential administrative penalties.
Corrective Action : The clinical team must defer Phase II exercise sessions until the patient has achieved 6 full weeks of clinical stability post-hospitalization on his current GDMT regimen. A formal re-evaluation note must be entered into the chart at week 6 confirming zero cardiovascular readmissions, stable diuretic and neurohormonal dosing, and persistent NYHA II-IV symptoms prior to initiating billable sessions.